{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:56:37Z","timestamp":1793814997069,"version":"4.6.1"},"reference-count":74,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T00:00:00Z","timestamp":1638144000000},"content-version":"vor","delay-in-days":581,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Khalifa Foundation - Abu Dhabi - United Arab Emirates"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>The outbreak of coronavirus disease 2019 (COVID-19) has rapidly spread globally since being identified as a public health emergency of major international concern and has now been declared a pandemic by the World Health Organization (WHO). In December 2019, an outbreak of atypical pneumonia, known as COVID-19, was identified in Wuhan, China. The newly identified zoonotic coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is characterized by rapid human-to-human transmission. Many cancer patients frequently visit the hospital for treatment and disease surveillance. They may be immunocompromised due to the underlying malignancy or anticancer therapy and are at higher risk of developing infections. Several factors increase the risk of infection, and cancer patients commonly have multiple risk factors. Cancer patients appear to have an estimated twofold increased risk of contracting SARS-CoV-2 than the general population. With the WHO declaring the novel coronavirus outbreak a pandemic, there is an urgent need to address the impact of such a pandemic on cancer patients. This include changes to resource allocation, clinical care, and the consent process during a pandemic. Currently and due to limited data, there are no international guidelines to address the management of cancer patients in any infectious pandemic. In this review, the potential challenges associated with managing cancer patients during the COVID-19 infection pandemic will be addressed, with suggestions of some practical approaches.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Implications for Practice<\/jats:title>\n                    <jats:p>The main management strategies for treating cancer patients during the COVID-19 epidemic include clear communication and education about hand hygiene, infection control measures, high-risk exposure, and the signs and symptoms of COVID-19. Consideration of risk and benefit for active intervention in the cancer population must be individualized. Postponing elective surgery or adjuvant chemotherapy for cancer patients with low risk of progression should be considered on a case-by-case basis. Minimizing outpatient visits can help to mitigate exposure and possible further transmission. Telemedicine may be used to support patients to minimize number of visits and risk of exposure. More research is needed to better understand SARS-CoV-2 virology and epidemiology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1634\/theoncologist.2020-0213","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T12:19:48Z","timestamp":1585916388000},"page":"e936-e945","source":"Crossref","is-referenced-by-count":504,"title":["A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group"],"prefix":"10.1093","volume":"25","author":[{"given":"Humaid O.","family":"Al-Shamsi","sequence":"first","affiliation":[{"name":"Medical Oncology Department, Alzahra Hospital Dubai, Dubai, United Arab Emirates"},{"name":"Department of Medicine, University of Sharjah, Sharjah, United Arab Emirates"},{"name":"Emirates Oncology Society, Dubai, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed","family":"Alhazzani","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, Medicine, McMaster University, Hamilton, Ontario, Canada"},{"name":"Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Alhuraiji","sequence":"additional","affiliation":[{"name":"Department of Hematology, Kuwait Cancer Control Center, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Coomes","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease, Department of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy F.","family":"Chemaly","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meshari","family":"Almuhanna","sequence":"additional","affiliation":[{"name":"Min-Sheng General Hospital, Taoyuan City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Wolff","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuhad K.","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melvin L.K.","family":"Chua","sequence":"additional","affiliation":[{"name":"Divisions of Radiation Oncology and Medical Sciences, National Cancer Center Singapore, Singapore"},{"name":"Oncology Academic Program, Duke-NUS Medical School, Singapore"},{"name":"Cong Hua's Institute, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien J.","family":"Hotte","sequence":"additional","affiliation":[{"name":"Department of Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon M.","family":"Meyers","sequence":"additional","affiliation":[{"name":"Department of Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Elfiki","sequence":"additional","affiliation":[{"name":"Windsor Regional Cancer Center, Windsor, Ontario, Canada"},{"name":"Department of Oncology, Schulich School of Medicine, University of Western Ontario, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Curigliano","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hemato-Oncology University of Milan, Milan, Italy"},{"name":"Division of Early Drug Development for Innovative Therapy, University of Milan, Milan, Italy"},{"name":"European Institute of Oncology, Milan, Italy"},{"name":"IRCCS, University of Milano, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Eng","sequence":"additional","affiliation":[{"name":"Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Grothey","sequence":"additional","affiliation":[{"name":"West Cancer Center, University of Tennessee, Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conghua","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,4,27]]},"reference":[{"key":"2021122510434755200_onco13306-bib-0001","author":"Worldometer"},{"key":"2021122510434755200_onco13306-bib-0002","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"2021122510434755200_onco13306-bib-0003","author":"Yu"},{"key":"2021122510434755200_onco13306-bib-0004","author":"World Health Organization"},{"key":"2021122510434755200_onco13306-bib-0005","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0140-6736(20)30567-5","article-title":"How will country-based mitigation measures influence the course of the COVID-19 epidemic?","volume":"395","author":"Anderson","year":"2020","journal-title":"Lancet"},{"key":"2021122510434755200_onco13306-bib-0006","author":"World Health Organization"},{"key":"2021122510434755200_onco13306-bib-0007","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China","volume":"21","author":"Liang","year":"2020","journal-title":"Lancet Oncol"},{"key":"2021122510434755200_onco13306-bib-0008","doi-asserted-by":"crossref","first-page":"221","DOI":"10.12688\/f1000research.5251.1","article-title":"Pandemic 2009 influenza A (H1N1) virus infection in cancer and hematopoietic stem cell transplant recipients; a multicenter observational study","volume":"3","author":"Dignani","year":"2014","journal-title":"F1000Res"},{"key":"2021122510434755200_onco13306-bib-0009","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3390\/curroncol13040012","article-title":"Influenza pandemic planning for cancer patients","volume":"13","author":"Battershill","year":"2006","journal-title":"Curr Oncol"},{"key":"2021122510434755200_onco13306-bib-0010"},{"key":"2021122510434755200_onco13306-bib-0011"},{"key":"2021122510434755200_onco13306-bib-0012"},{"key":"2021122510434755200_onco13306-bib-0013","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"2021122510434755200_onco13306-bib-0014","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1056\/NEJMe2001126","article-title":"Another decade, another coronavirus","volume":"382","author":"Perlman","year":"2020","journal-title":"N Engl J Med"},{"key":"2021122510434755200_onco13306-bib-0015","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"N Engl J Med"},{"key":"2021122510434755200_onco13306-bib-0016","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","article-title":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster","volume":"395","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"2021122510434755200_onco13306-bib-0017","author":"Novel Coronavirus Pneumonia Emergency Response Epidemiology Team"},{"key":"2021122510434755200_onco13306-bib-0018"},{"key":"2021122510434755200_onco13306-bib-0019","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.4683","article-title":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy","author":"Onder","year":"2020","journal-title":"JAMA"},{"key":"2021122510434755200_onco13306-bib-0020","article-title":"Care of haematology patients in a COVID-19 epidemic","author":"Willan","year":"2020","journal-title":"Br J Haematol"},{"key":"2021122510434755200_onco13306-bib-0021","author":"The Cancer Letter"},{"key":"2021122510434755200_onco13306-bib-0022","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.0004-8461.2003.01165.x","article-title":"Hiding in the bunker: Challenges for a radiation oncology department operating in the severe acute respiratory syndrome outbreak","volume":"47","author":"Mukherjee","year":"2003","journal-title":"Australas Radiol"},{"key":"2021122510434755200_onco13306-bib-0023"},{"key":"2021122510434755200_onco13306-bib-0024","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/cpt.1390","article-title":"Impact of oncology drug shortages on chemotherapy treatment","volume":"106","author":"Alpert","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"2021122510434755200_onco13306-bib-0025","author":"U.S. Food & Drug Administration"},{"key":"2021122510434755200_onco13306-bib-0026","author":"U.S. Food & Drug Administration"},{"key":"2021122510434755200_onco13306-bib-0027","author":"Vox"},{"key":"2021122510434755200_onco13306-bib-0028","first-page":"740","article-title":"The drug shortage crisis in the United States: Causes, impact, and management strategies","volume":"36","author":"Ventola","year":"2011","journal-title":"P T"},{"key":"2021122510434755200_onco13306-bib-0029","author":"Repici","year":"2020"},{"key":"2021122510434755200_onco13306-bib-0030","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.lungcan.2004.01.002","article-title":"Impact of severe acute respiratory syndrome on the status of lung cancer chemotherapy patients and a correlation of the signs and symptoms","volume":"45","author":"Chen","year":"2004","journal-title":"Lung Cancer"},{"key":"2021122510434755200_onco13306-bib-0031","author":"CBC News"},{"key":"2021122510434755200_onco13306-bib-0032","article-title":"Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19)","author":"Nishiura","year":"2020","journal-title":"Int J Infect Dis"},{"key":"2021122510434755200_onco13306-bib-0033","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.10.2000180","article-title":"Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020","volume":"25","author":"Mizumoto","year":"2020","journal-title":"Euro Surveill"},{"key":"2021122510434755200_onco13306-bib-0034","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy053","article-title":"Outpatient infection prevention: A practical primer","volume":"5","author":"Steinkuller","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2021122510434755200_onco13306-bib-0035","author":"World Health rganization"},{"key":"2021122510434755200_onco13306-bib-0036","first-page":"1","article-title":"Guidelines for preventing health-care-associated pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee","volume":"53","author":"Tablan","year":"2004","journal-title":"MMWR Recomm Rep"},{"key":"2021122510434755200_onco13306-bib-0037","author":"Centers for Disease Contro and Prevention"},{"key":"2021122510434755200_onco13306-bib-0038","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1470-2045(12)70116-X","article-title":"Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: A randomised, multicentre, non-inferiority, phase 3 trial","volume":"13","author":"Hofheinz","year":"2012","journal-title":"Lancet Oncol"},{"key":"2021122510434755200_onco13306-bib-0039","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/j.clcc.2017.01.009","article-title":"Comparison of 5-fu-based and capecitabine-based neoadjuvant chemoradiotherapy in patients with rectal cancer: A meta-analysis","volume":"16","author":"Zou","year":"2017","journal-title":"Clin Colorectal Cancer"},{"key":"2021122510434755200_onco13306-bib-0040","doi-asserted-by":"crossref","first-page":"482","DOI":"10.12968\/bjcn.2019.24.10.482","article-title":"Delivering chemotherapy at home: How much do we know?","volume":"24","author":"Shereen","year":"2019","journal-title":"Br nursing Community Nurs"},{"key":"2021122510434755200_onco13306-bib-0041","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1200\/JOP.2012.000719","article-title":"Baseline blood work before initiation of chemotherapy: What is safe in the real world?","volume":"9","author":"Warr","year":"2013","journal-title":"J Oncol Pract"},{"key":"2021122510434755200_onco13306-bib-0042","author":"The New York Times"},{"key":"2021122510434755200_onco13306-bib-0043","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1200\/EDBK_200141","article-title":"Telemedicine in cancer care","volume":"38","author":"Sirintrapun","year":"2018","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"2021122510434755200_onco13306-bib-0044","author":"Doremalen"},{"key":"2021122510434755200_onco13306-bib-0045","author":"ASTRO"},{"key":"2021122510434755200_onco13306-bib-0046","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120827","article-title":"Hospital admission of cancer patients: Avoidable practice or necessary care?","volume":"10","author":"Numico","year":"2015","journal-title":"PLoS One"},{"key":"2021122510434755200_onco13306-bib-0047","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1097\/MLR.0b013e3181792525","article-title":"Health impact of hospital restrictions on seriously ill hospitalized patients: Lessons from the Toronto SARS outbreak","volume":"46","author":"Stukel","year":"2008","journal-title":"Med Care"},{"key":"2021122510434755200_onco13306-bib-0048","author":"European Centre for Disease Prevention and Control"},{"key":"2021122510434755200_onco13306-bib-0049","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.3972","article-title":"Supporting the health care workforce during the COVID-19 global epidemic","author":"Adams","year":"2020","journal-title":"JAMA"},{"key":"2021122510434755200_onco13306-bib-0050","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1016\/j.ejca.2015.08.016","article-title":"Timing of adjuvant chemotherapy and its relation to survival among patients with stage iii colon cancer","volume":"51","author":"Bos","year":"2015","journal-title":"Eur J Cancer"},{"key":"2021122510434755200_onco13306-bib-0051","author":"American College of Surgeons"},{"key":"2021122510434755200_onco13306-bib-0052","author":"Centers for Disease Control And Prevention"},{"key":"2021122510434755200_onco13306-bib-0053","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/tbj.12758","article-title":"Timing of breast cancer surgery-how much does it matter?","volume":"23","author":"Mansfield","year":"2017","journal-title":"Breast J"},{"key":"2021122510434755200_onco13306-bib-0054","author":"American College of Surgeons"},{"key":"2021122510434755200_onco13306-bib-0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40880-019-0368-6","article-title":"Current cancer situation in china: Good or bad news from the 2018 global cancer statistics?","volume":"39","author":"Feng","year":"2019","journal-title":"Cancer Commun (Lond)"},{"key":"2021122510434755200_onco13306-bib-0056","article-title":"Diagnostic and therapeutic strategies of lung cancer patients during the outbreak of 2019 novel coronavirus disease (COVID-19) [in Chinese]","volume":"42","author":"Yang","year":"2020","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"2021122510434755200_onco13306-bib-0057","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/1471-2334-10-340","article-title":"Flocked nasal swab versus nasopharyngeal aspirate for detection of respiratory tract viruses in immunocompromised adults: A matched comparative study","volume":"10","author":"Ohrmalm","year":"2010","journal-title":"BMC Infect Dis"},{"key":"2021122510434755200_onco13306-bib-0058","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.bbmt.2018.03.004","article-title":"Viral respiratory tract infections in allogeneic hematopoietic stem cell transplantation recipients in the era of molecular testing","volume":"24","author":"Sim","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"2021122510434755200_onco13306-bib-0059","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.2165\/00003495-200767100-00004","article-title":"Viral respiratory tract infections in transplant patients: Epidemiology, recognition and management","volume":"67","author":"Lee","year":"2007","journal-title":"Drugs"},{"key":"2021122510434755200_onco13306-bib-0060","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/cid\/cis844","article-title":"Fourth European Conference on Infections in Leukaemia (ECIL-4): Guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus","volume":"56","author":"Hirsch","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"Suppl 5","key":"2021122510434755200_onco13306-bib-0061","doi-asserted-by":"crossref","first-page":"S344","DOI":"10.1093\/cid\/ciu623","article-title":"Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies","volume":"59","author":"Chemaly","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2021122510434755200_onco13306-bib-0062","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/clinids\/22.5.778","article-title":"Community respiratory virus infections among hospitalized adult bone marrow transplant recipients","volume":"22","author":"Whimbey","year":"1996","journal-title":"Clin Infect Dis"},{"key":"2021122510434755200_onco13306-bib-0063","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/bjh.14027","article-title":"BCSH\/BSBMT\/UK clinical virology network guideline: Diagnosis and management of common respiratory viral infections in patients undergoing treatment for haematological malignancies or stem cell transplantation","volume":"173","author":"Dignan","year":"2016","journal-title":"Br J Haematol"},{"key":"2021122510434755200_onco13306-bib-0064","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jcv.2011.07.015","article-title":"Non-invasive sample collection for respiratory virus testing by multiplex PCR","volume":"52","author":"Blaschke","year":"2011","journal-title":"J Clin Virol"},{"key":"2021122510434755200_onco13306-bib-0065","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/cid\/civ272","article-title":"Clinical outcomes associated with respiratory virus detection before allogeneic hematopoietic stem cell transplant","volume":"61","author":"Campbell","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2021122510434755200_onco13306-bib-0066","author":"EBMT"},{"key":"2021122510434755200_onco13306-bib-0067","author":"U.S. Food & Drug Administration"},{"key":"2021122510434755200_onco13306-bib-0068","author":"World Health Organization"},{"key":"2021122510434755200_onco13306-bib-0069"},{"key":"2021122510434755200_onco13306-bib-0070"},{"key":"2021122510434755200_onco13306-bib-0071","volume-title":"Integrating clinical research into epidemic response: The Ebola experience. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Board on Global Health; Committee on Clinical Trials During the 2014\u20132015 Ebola Outbreak","author":"Busta","year":"2017"},{"key":"2021122510434755200_onco13306-bib-0072"},{"key":"2021122510434755200_onco13306-bib-0073","author":"The Medical Journal of Australia"},{"key":"2021122510434755200_onco13306-bib-0074"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1634%2Ftheoncologist.2020-0213","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.2020-0213","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.2020-0213","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/25\/6\/e936\/41918658\/oncolo_25_6_e936.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/25\/6\/e936\/41918658\/oncolo_25_6_e936.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,25]],"date-time":"2021-12-25T05:44:56Z","timestamp":1640411096000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/25\/6\/e936\/6443401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,27]]},"references-count":74,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,4,27]]},"published-print":{"date-parts":[[2020,6,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2020-0213","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,6,1]]},"published":{"date-parts":[[2020,4,27]]}}}